🚨 New trial alert! In youth with type 1 diabetes, adding #SGLT2i 💊 (dapagliflozin) to insulin:
✅ Reduced glomerular hyperfiltration
✅ Lowered HbA1c 📉
✅ Boosted time-in-range ⏱️
😌 Safe with DKA precautions in place
📄 #ATTEMPTTrial | @NatureMedicine
🔗 https://doi.org/10.1038/s41591-025-03723-6
